Breast Cancer Clinical Trial
A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancer
Summary
The purpose of this study is to test the hypothesis that an intervention of lifestyle modification will positively impact women with breast cancer who are overweight and/or obese. To that end, our primary endpoint is to examine the effects of a practical lifestyle intervention that can be implemented by overweight or obese women (BMI greater or equal to 25) with early stage breast cancer (I-III) on outcomes such as body weight and change in BMI over the course of the study.
Full Description
Primary endpoint: To examine the effects of a practical lifestyle intervention that can be implemented by overweight or obese women (BMI greater or equal to 25) with early stage breast cancer (I-III) on outcomes such as body weight and change in BMI over the course of the study.
Secondary endpoint: To assess the impact of such intervention on lipid profiles and hemoglobin A1C. The study group will be compared with a historical control group of patients with early stage breast cancer who are obese or overweight who were not given the intervention
Secondary endpoint: To examine whether an active intervention program will lead into longstanding lifestyle modification in breast cancer patients with a BMI greater or equal to 25.
Eligibility Criteria
Inclusion Criteria:
DCIS
Women with stage 0 - III breast cancer (histologic type ductal or lobular)
BMI >=25
Patients must have completed all chemotherapy
Patients may be on hormonal therapy or radiation therapy
Age >= 18 years old to 89 Years old
Patient must be medically stable and without significant impairments that would preclude following the proposed intervention regimen.
Time of diagnosis: patients enrolled are within 1 month to 18 months post-diagnosis.
Exclusion Criteria:
Metastatic breast cancer patients and patients with inoperable or active loco-regional disease.
Patients following alternative/complementary diets or taking high dose antioxidant supplements.
Patients with a physical/psychiatric impairment that would seriously impair their physical mobility.
Patients who are currently suffering from severe nausea, anorexia or other diseases affecting health (e.g. arthritis and multiple sclerosis).
Patients younger than 18 and older than 89 years.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Miami Florida, 33143, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.